News

Bayer makes $165,000 available to support rural-based charities

Bayer Canada Named one of Canada’s Most Admired™ Corporate Cultures

Bayer Crop Science Launches 2022 Opportunity Scholarship Program for Students

Bayer extends clinical development program for finerenone with Phase II study investigating the initial combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes

Rural-based charities a little richer with the help of Canadian farmers and the Bayer Fund’s Canada’s Farmers Grow Communities Program

New analyses of the comprehensive finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D, independent of baseline therapy

Bayer Fund supports future agriculture leaders with $93,000 in Post-secondary scholarship funding